Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q87824523 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241121000340.0 | ||
| 008 | 241121nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q87824523 | ||
| 024 | ‡a 0000-0003-1377-9685 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q87824523 | ||
| 100 | 0 | ‡a Y Xiao ‡c researcher ‡9 en | |
| 400 | 0 | ‡a Y Xiao ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's A novel germline EGFR variant p.R831H causes predisposition to familial CDK12-mutant prostate cancer with tandem duplicator phenotype | ||
| 670 | ‡a Author's An outcome model for human bladder cancer: A comprehensive study based on weighted gene co-expression network analysis | ||
| 670 | ‡a Author's Comprehensive genomic profiling of urothelial carcinoma cell lines reveals hidden research bias and caveats | ||
| 670 | ‡a Author's Conditional reprogramming: Modeling urological cancer and translation to clinics | ||
| 670 | ‡a Author's Downregulation of TRPM7 suppressed migration and invasion by regulating epithelial-mesenchymal transition in prostate cancer cells | ||
| 670 | ‡a Author's Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPARγ-mediated pathway in bladder cancer | ||
| 670 | ‡a Author's Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis | ||
| 670 | ‡a Author's Identification of a prognostic gene signature based on an immunogenomic landscape analysis of bladder cancer | ||
| 670 | ‡a Author's Identification of several cell cycle relevant genes highly correlated with the progression and prognosis of human bladder urothelial tumor | ||
| 670 | ‡a Author's Immune-related signature predicts the prognosis and immunotherapy benefit in bladder cancer | ||
| 670 | ‡a Author's Inhibition of MELK produces potential anti-tumour effects in bladder cancer by inducing G1/S cell cycle arrest via the ATM/CHK2/p53 pathway | ||
| 670 | ‡a Author's Knockdown of SIRT1 Suppresses Bladder Cancer Cell Proliferation and Migration and Induces Cell Cycle Arrest and Antioxidant Response through FOXO3a-Mediated Pathways. | ||
| 670 | ‡a Author's Pedigree analysis of a POLD1 germline mutation in urothelial carcinoma shows a close association between different mutation burdens and overall survival | ||
| 670 | ‡a Author's PPARγ inhibition regulates the cell cycle, proliferation and motility of bladder cancer cells | ||
| 670 | ‡a Author's Prognostic value of a gene signature in clear cell renal cell carcinoma | ||
| 670 | ‡a Author's SPOP suppresses prostate cancer through regulation of CYCLIN E1 stability | ||
| 670 | ‡a Author's The applied value of medical history, physical examination, colour-Doppler ultrasonography and testis scintigraphy in the differential diagnosis of acute scrotum. | ||
| 670 | ‡a Author's TRPM8 Inhibition Regulates the Proliferation, Migration and ROS Metabolism of Bladder Cancer Cells | ||
| 670 | ‡a Author's WFDC2 suppresses prostate cancer metastasis by modulating EGFR signaling inactivation | ||
| 909 | ‡a (orcid) 0000000313779685 ‡9 1 | ||
| 919 | ‡a spopsuppressesprostatecancerthroughregulationofcycline1stability ‡A SPOP suppresses prostate cancer through regulation of CYCLIN E1 stability ‡9 1 | ||
| 919 | ‡a appliedvalueofmedicalhistoryphysicalexaminationcolourdopplerultrasonographyandtestisscintigraphyinthedifferentialdiagnosisofacutescrotum ‡A The applied value of medical history, physical examination, colour-Doppler ultrasonography and testis scintigraphy in the differential diagnosis of acute scrotum. ‡9 1 | ||
| 919 | ‡a trpm8inhibitionregulatestheproliferationmigrationandrosmetabolismofbladdercancercells ‡A TRPM8 Inhibition Regulates the Proliferation, Migration and ROS Metabolism of Bladder Cancer Cells ‡9 1 | ||
| 919 | ‡a wfdc2suppressesprostatecancermetastasisbymodulatingegfrsignalinginactivation ‡A WFDC2 suppresses prostate cancer metastasis by modulating EGFR signaling inactivation ‡9 1 | ||
| 919 | ‡a novelgermlineegfrvariantpr831hcausespredispositiontofamilialcdk12mutantprostatecancerwithtandemduplicatorphenotype ‡A A novel germline EGFR variant p.R831H causes predisposition to familial CDK12-mutant prostate cancer with tandem duplicator phenotype ‡9 1 | ||
| 919 | ‡a outcomemodelforhumanbladdercanceracomprehensivestudybasedonweightedgenecoexpressionnetworkanalysis ‡A An outcome model for human bladder cancer: A comprehensive study based on weighted gene co-expression network analysis ‡9 1 | ||
| 919 | ‡a comprehensivegenomicprofilingofurothelialcarcinomacelllinesrevealshiddenresearchbiasandcaveats ‡A Comprehensive genomic profiling of urothelial carcinoma cell lines reveals hidden research bias and caveats ‡9 1 | ||
| 919 | ‡a conditionalreprogrammingmodelingurologicalcancerandtranslationtoclinics ‡A Conditional reprogramming: Modeling urological cancer and translation to clinics ‡9 1 | ||
| 919 | ‡a downregulationoftrpm7suppressedmigrationandinvasionbyregulatingepithelialmesenchymaltransitioninprostatecancercells ‡A Downregulation of TRPM7 suppressed migration and invasion by regulating epithelial-mesenchymal transition in prostate cancer cells ‡9 1 | ||
| 919 | ‡a fattyacidoxidationinhibitoretomoxirsuppressestumorprogressionandinducescellcyclearrestviapparγmediatedpathwayinbladdercancer ‡A Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPARγ-mediated pathway in bladder cancer ‡9 1 | ||
| 919 | ‡a 15hubgenesassociatedwithprogressionandprognosisofclearcellrenalcellcarcinomaidentifiedbycoexpressionanalysis ‡A Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis ‡9 1 | ||
| 919 | ‡a identificationofaprognosticgenesignaturebasedonanimmunogenomiclandscapeanalysisofbladdercancer ‡A Identification of a prognostic gene signature based on an immunogenomic landscape analysis of bladder cancer ‡9 1 | ||
| 919 | ‡a identificationofseveralcellcyclerelevantgeneshighlycorrelatedwiththeprogressionandprognosisofhumanbladderurothelialtumor ‡A Identification of several cell cycle relevant genes highly correlated with the progression and prognosis of human bladder urothelial tumor ‡9 1 | ||
| 919 | ‡a immunerelatedsignaturepredictstheprognosisandimmunotherapybenefitinbladdercancer ‡A Immune-related signature predicts the prognosis and immunotherapy benefit in bladder cancer ‡9 1 | ||
| 919 | ‡a inhibitionofmelkproducespotentialantitumoureffectsinbladdercancerbyinducingg1scellcyclearrestviatheatmchk2p53pathway ‡A Inhibition of MELK produces potential anti-tumour effects in bladder cancer by inducing G1/S cell cycle arrest via the ATM/CHK2/p53 pathway ‡9 1 | ||
| 919 | ‡a knockdownofsirt1suppressesbladdercancercellproliferationandmigrationandinducescellcyclearrestandantioxidantresponsethroughfoxo3amediatedpathways ‡A Knockdown of SIRT1 Suppresses Bladder Cancer Cell Proliferation and Migration and Induces Cell Cycle Arrest and Antioxidant Response through FOXO3a-Mediated Pathways. ‡9 1 | ||
| 919 | ‡a pedigreeanalysisofapold1germlinemutationinurothelialcarcinomashowsacloseassociationbetweendifferentmutationburdensandoverallsurvival ‡A Pedigree analysis of a POLD1 germline mutation in urothelial carcinoma shows a close association between different mutation burdens and overall survival ‡9 1 | ||
| 919 | ‡a pparγinhibitionregulatesthecellcycleproliferationandmotilityofbladdercancercells ‡A PPARγ inhibition regulates the cell cycle, proliferation and motility of bladder cancer cells ‡9 1 | ||
| 919 | ‡a prognosticvalueofagenesignatureinclearcellrenalcellcarcinoma ‡A Prognostic value of a gene signature in clear cell renal cell carcinoma ‡9 1 | ||
| 996 | ‡2 NII|DA12179807 | ||
| 996 | ‡2 ISNI|000000006382901X | ||
| 996 | ‡2 DNB|136778186 | ||
| 996 | ‡2 ISNI|0000000115151256 | ||
| 996 | ‡2 LC|nr 97005205 | ||
| 996 | ‡2 LC|n 2010048601 | ||
| 996 | ‡2 NII|DA10186481 | ||
| 996 | ‡2 LC|n 79034658 | ||
| 996 | ‡2 BNF|15031701 | ||
| 996 | ‡2 CYT|AC000120705 | ||
| 996 | ‡2 ISNI|0000000063443213 | ||
| 996 | ‡2 LC|n 2010022396 | ||
| 996 | ‡2 CYT|AC000640198 | ||
| 996 | ‡2 SUDOC|232918880 | ||
| 996 | ‡2 ISNI|0000000063497262 | ||
| 996 | ‡2 LC|n 97112883 | ||
| 996 | ‡2 DNB|1300259892 | ||
| 996 | ‡2 ISNI|0000000053758043 | ||
| 996 | ‡2 NUKAT|n 2012151225 | ||
| 996 | ‡2 DNB|1192515064 | ||
| 996 | ‡2 CYT|AC000295637 | ||
| 996 | ‡2 LC|n 2007185524 | ||
| 996 | ‡2 LC|no2015146119 | ||
| 996 | ‡2 NTA|190771445 | ||
| 996 | ‡2 LC|nr 98036483 | ||
| 996 | ‡2 LC|n 2014049788 | ||
| 996 | ‡2 LC|nr 88004689 | ||
| 996 | ‡2 CAOONL|ncf10728851 | ||
| 996 | ‡2 ISNI|0000000046309143 | ||
| 996 | ‡2 ISNI|0000000064153023 | ||
| 996 | ‡2 ISNI|0000000454791151 | ||
| 996 | ‡2 LC|n 93110808 | ||
| 996 | ‡2 BNF|14611981 | ||
| 996 | ‡2 LC|nr2002024615 | ||
| 996 | ‡2 DNB|1180767462 | ||
| 996 | ‡2 DNB|1026214882 | ||
| 996 | ‡2 ISNI|0000000092187335 | ||
| 996 | ‡2 LC|n 2011061158 | ||
| 996 | ‡2 LC|no2022072187 | ||
| 996 | ‡2 DNB|1287061001 | ||
| 996 | ‡2 SUDOC|252644107 | ||
| 996 | ‡2 ISNI|0000000050484657 | ||
| 996 | ‡2 CYT|AC000619265 | ||
| 996 | ‡2 NTA|174418833 | ||
| 996 | ‡2 DNB|120466210X | ||
| 996 | ‡2 DNB|1237819318 | ||
| 996 | ‡2 ISNI|0000000037082733 | ||
| 996 | ‡2 ISNI|0000000064210964 | ||
| 996 | ‡2 LC|n 84043018 | ||
| 996 | ‡2 BNF|16694270 | ||
| 996 | ‡2 LC|no2008132586 | ||
| 996 | ‡2 LC|n 2005078128 | ||
| 996 | ‡2 PLWABN|9811518889005606 | ||
| 996 | ‡2 J9U|987007400206205171 | ||
| 996 | ‡2 LC|no2005046683 | ||
| 996 | ‡2 ISNI|0000000044102675 | ||
| 996 | ‡2 DNB|173724108 | ||
| 996 | ‡2 ERRR|12350345 | ||
| 996 | ‡2 LC|n 2024037734 | ||
| 996 | ‡2 BNF|15739567 | ||
| 996 | ‡2 DNB|1251842003 | ||
| 996 | ‡2 DNB|1265522316 | ||
| 996 | ‡2 BNF|17716783 | ||
| 996 | ‡2 SUDOC|069720134 | ||
| 996 | ‡2 DNB|120549829X | ||
| 996 | ‡2 DNB|112512279X | ||
| 996 | ‡2 ISNI|0000000055245831 | ||
| 996 | ‡2 LC|no2004122783 | ||
| 996 | ‡2 SELIBR|302188 | ||
| 996 | ‡2 ISNI|0000000116899354 | ||
| 996 | ‡2 LC|n 2015020543 | ||
| 996 | ‡2 ISNI|0000000391075894 | ||
| 996 | ‡2 RERO|A027114311 | ||
| 996 | ‡2 DNB|1253457042 | ||
| 996 | ‡2 SUDOC|095757929 | ||
| 996 | ‡2 LC|no2008183947 | ||
| 996 | ‡2 LC|n 87921016 | ||
| 996 | ‡2 DNB|1181003016 | ||
| 996 | ‡2 ISNI|0000000064265199 | ||
| 996 | ‡2 NII|DA11665945 | ||
| 996 | ‡2 ISNI|0000000004843655 | ||
| 996 | ‡2 LC|nr 92001374 | ||
| 996 | ‡2 KRNLK|KAC200208450 | ||
| 996 | ‡2 NTA|157399818 | ||
| 996 | ‡2 DNB|171875451 | ||
| 996 | ‡2 NTA|159234263 | ||
| 996 | ‡2 DNB|143516957 | ||
| 996 | ‡2 CYT|AC000007618 | ||
| 996 | ‡2 DNB|1273780507 | ||
| 996 | ‡2 NTA|095781617 | ||
| 996 | ‡2 DNB|1235786862 | ||
| 996 | ‡2 CYT|AC000120833 | ||
| 996 | ‡2 ISNI|0000000449654822 | ||
| 996 | ‡2 ISNI|0000000382908022 | ||
| 996 | ‡2 RERO|A028112936 | ||
| 996 | ‡2 ISNI|0000000047766637 | ||
| 996 | ‡2 CYT|AC000652774 | ||
| 996 | ‡2 DNB|171450663 | ||
| 996 | ‡2 DNB|128707314X | ||
| 996 | ‡2 LC|n 2011030081 | ||
| 996 | ‡2 BNF|17909526 | ||
| 996 | ‡2 ISNI|0000000121944535 | ||
| 996 | ‡2 LC|no2013020017 | ||
| 996 | ‡2 LC|n 2015015354 | ||
| 996 | ‡2 DNB|1074878477 | ||
| 996 | ‡2 LC|n 2013044396 | ||
| 996 | ‡2 CYT|AC000229481 | ||
| 996 | ‡2 LC|no2021044158 | ||
| 996 | ‡2 NTA|151502773 | ||
| 996 | ‡2 ISNI|0000000439578141 | ||
| 996 | ‡2 DNB|1270536184 | ||
| 996 | ‡2 NTA|182137961 | ||
| 996 | ‡2 ISNI|0000000064183724 | ||
| 996 | ‡2 SUDOC|109305698 | ||
| 996 | ‡2 NUKAT|n 2018155743 | ||
| 996 | ‡2 ISNI|0000000046973511 | ||
| 996 | ‡2 DNB|124940777X | ||
| 996 | ‡2 DNB|1268473502 | ||
| 996 | ‡2 LC|nr 99025755 | ||
| 996 | ‡2 DNB|1203822286 | ||
| 996 | ‡2 CYT|AC000315038 | ||
| 996 | ‡2 NUKAT|n 2020213508 | ||
| 996 | ‡2 LC|no2010027647 | ||
| 996 | ‡2 ISNI|0000000444591754 | ||
| 996 | ‡2 CYT|AC000135075 | ||
| 996 | ‡2 DNB|1089080964 | ||
| 996 | ‡2 PTBNP|1705760 | ||
| 996 | ‡2 LC|no2010200721 | ||
| 996 | ‡2 LC|n 82078933 | ||
| 996 | ‡2 ISNI|0000000064143060 | ||
| 996 | ‡2 CYT|AC000394884 | ||
| 996 | ‡2 ISNI|0000000040206995 | ||
| 996 | ‡2 LC|n 2018064940 | ||
| 996 | ‡2 BIBSYS|1086144 | ||
| 996 | ‡2 DNB|1116383632 | ||
| 996 | ‡2 CYT|AC000632823 | ||
| 996 | ‡2 LC|no2019129150 | ||
| 996 | ‡2 DNB|1045983772 | ||
| 996 | ‡2 LC|no2019020612 | ||
| 996 | ‡2 RERO|A026810327 | ||
| 996 | ‡2 LC|nr 92044056 | ||
| 996 | ‡2 ISNI|0000000036234299 | ||
| 996 | ‡2 LC|no2019080850 | ||
| 996 | ‡2 DNB|173513239 | ||
| 996 | ‡2 ISNI|0000000495939634 | ||
| 996 | ‡2 CYT|AC000347395 | ||
| 996 | ‡2 CYT|AC000000340 | ||
| 996 | ‡2 ISNI|0000000447499400 | ||
| 996 | ‡2 ISNI|000000009556823X | ||
| 996 | ‡2 CYT|AC000229543 | ||
| 996 | ‡2 LC|no2007000735 | ||
| 996 | ‡2 SUDOC|104619686 | ||
| 996 | ‡2 NUKAT|n 2015066950 | ||
| 996 | ‡2 CYT|AC000631186 | ||
| 996 | ‡2 CYT|AC000652690 | ||
| 996 | ‡2 DNB|1236519035 | ||
| 996 | ‡2 PTBNP|1396772 | ||
| 996 | ‡2 ISNI|0000000120560986 | ||
| 996 | ‡2 DNB|121663498X | ||
| 996 | ‡2 J9U|987012502007005171 | ||
| 996 | ‡2 PLWABN|9810682625505606 | ||
| 996 | ‡2 LC|no2011155392 | ||
| 996 | ‡2 CYT|AC000246703 | ||
| 996 | ‡2 ISNI|0000000063359484 | ||
| 996 | ‡2 NII|DA12129707 | ||
| 996 | ‡2 DNB|1237002915 | ||
| 996 | ‡2 LC|no2006062501 | ||
| 996 | ‡2 LC|n 2018187456 | ||
| 996 | ‡2 CYT|AC000320247 | ||
| 996 | ‡2 ISNI|0000000063904745 | ||
| 996 | ‡2 BIBSYS|1634281498079 | ||
| 996 | ‡2 LC|nr 98022674 | ||
| 996 | ‡2 NYNYRILM|45160 | ||
| 996 | ‡2 LC|n 84226472 | ||
| 996 | ‡2 CYT|AC000363768 | ||
| 996 | ‡2 DNB|1288901100 | ||
| 996 | ‡2 ISNI|0000000067307382 | ||
| 996 | ‡2 DNB|172594278 | ||
| 996 | ‡2 ISNI|0000000063380275 | ||
| 996 | ‡2 CAOONL|ncf13767936 | ||
| 996 | ‡2 LC|n 86034769 | ||
| 996 | ‡2 DNB|1163206636 | ||
| 996 | ‡2 DNB|1332666035 | ||
| 996 | ‡2 NUKAT|n 2014064381 | ||
| 996 | ‡2 DNB|1063003881 | ||
| 996 | ‡2 ISNI|0000000064238406 | ||
| 996 | ‡2 ISNI|0000000063658716 | ||
| 996 | ‡2 LC|n 89118063 | ||
| 996 | ‡2 LC|n 2010036174 | ||
| 996 | ‡2 CYT|AC000663019 | ||
| 996 | ‡2 LNB|LNC10-000168265 | ||
| 996 | ‡2 LC|n 2005061372 | ||
| 996 | ‡2 J9U|987007579731705171 | ||
| 996 | ‡2 LC|no2008144274 | ||
| 996 | ‡2 LC|n 84226398 | ||
| 996 | ‡2 NKC|stk2008461973 | ||
| 996 | ‡2 CYT|AC000652882 | ||
| 996 | ‡2 DNB|131414099X | ||
| 996 | ‡2 BNF|16558429 | ||
| 996 | ‡2 LC|n 2010067916 | ||
| 996 | ‡2 CYT|AC000442307 | ||
| 996 | ‡2 LC|nr2001003911 | ||
| 996 | ‡2 DNB|1194352707 | ||
| 996 | ‡2 LC|n 2010067912 | ||
| 996 | ‡2 CYT|AC000539579 | ||
| 996 | ‡2 NUKAT|n 2012150391 | ||
| 996 | ‡2 DNB|1315555360 | ||
| 996 | ‡2 DNB|1129611345 | ||
| 996 | ‡2 NSK|000593744 | ||
| 996 | ‡2 DNB|1272834751 | ||
| 996 | ‡2 LC|n 2012072260 | ||
| 996 | ‡2 DNB|1158625049 | ||
| 996 | ‡2 DNB|14078585X | ||
| 996 | ‡2 BNF|16718025 | ||
| 996 | ‡2 CAOONL|ncf10665707 | ||
| 996 | ‡2 NII|DA09667303 | ||
| 996 | ‡2 DNB|1315286661 | ||
| 996 | ‡2 CYT|AC000631850 | ||
| 996 | ‡2 CYT|AC000020446 | ||
| 996 | ‡2 LC|n 88034299 | ||
| 996 | ‡2 LC|no2008063820 | ||
| 996 | ‡2 CYT|AC000121164 | ||
| 996 | ‡2 LC|n 2008081500 | ||
| 996 | ‡2 NTA|315033940 | ||
| 996 | ‡2 NTA|423207385 | ||
| 996 | ‡2 DNB|1287292488 | ||
| 996 | ‡2 LC|no2023090421 | ||
| 996 | ‡2 ISNI|0000000064368809 | ||
| 996 | ‡2 SUDOC|237558475 | ||
| 996 | ‡2 CYT|AC000567988 | ||
| 996 | ‡2 LC|no2022105346 | ||
| 996 | ‡2 CYT|AC000042828 | ||
| 996 | ‡2 CYT|AC000547577 | ||
| 996 | ‡2 LC|n 2007073077 | ||
| 996 | ‡2 ISNI|0000000449695181 | ||
| 996 | ‡2 ISNI|0000000063662651 | ||
| 996 | ‡2 NUKAT|n 2004044998 | ||
| 996 | ‡2 DNB|1322748438 | ||
| 996 | ‡2 ISNI|0000000063714167 | ||
| 996 | ‡2 CYT|AC000326082 | ||
| 996 | ‡2 DNB|1210176459 | ||
| 996 | ‡2 BIBSYS|11063647 | ||
| 996 | ‡2 LC|n 2012013872 | ||
| 996 | ‡2 DNB|1264094116 | ||
| 996 | ‡2 NTA|149266596 | ||
| 996 | ‡2 LC|no2018020496 | ||
| 996 | ‡2 NII|DA11087532 | ||
| 996 | ‡2 CYT|AC000660862 | ||
| 996 | ‡2 LC|n 2013044029 | ||
| 996 | ‡2 DNB|142137782 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
